Back to results
US 2016/0101072 A1Published application
Therapeutic uses of enzyme inhibitors
AssigneeProximagen Limited
InventorsKenneth Mulvany, Martyn Pritchard
Life of this patent
Estimating the term…
Abstract
The invention relates to use of compounds which inhibit VAP-1/SSAO activity for the treatment of muscular dystrophy. The invention also relates to combined preparations comprising compounds which inhibit VAP-1/SSAO activity, and their use for the treatment of muscular dystrophy.
Claims20
A method of treating muscular dystrophy comprising administering to a subject suffering such disease an effective amount of a VAP-1 inhibitor compound.
A pharmaceutical composition comprising:
- (a) a VAP-1 inhibitor compound;
- (b) a steroid;
- and
- (c) a pharmaceutically acceptable carrier, excipient, or diluent.
1 more element
A method of treating muscular dystrophy comprising administering to a subject suffering such disease a pharmaceutical composition comprising:
- (a) a VAP-1 inhibitor compound;
- (b) a steroid;
- and
- (c) a pharmaceutically acceptable carrier, excipient, or diluent.
1 more element
Dependencies are inferred from the claim text.